InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Newcomer Lee Nisley. Director active across 2 companies, notably Myriad Genetics INC. Aggregated, 7 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €145k. History available since 3 June 2021. The latest transaction was filed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Newcomer Lee Nisley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
30,000 股0Common StockSEC:0001610717-26-000204:0
49,796 股0Common StockSEC:0001628280-25-029974:0
15,695 股0Common StockSEC:0001628280-24-027333:0
6,200 股@ US$25.30100.0% 占其流量Common StockSEC:0001788981-24-000002:0
15,151 股0Common StockSEC:0001788981-23-000002:0
17,275 股0Common StockSEC:0001628280-22-016220:0
12,848 股0Common StockSEC:0001788981-21-000002:0
7 条申报中的 7 条
About Newcomer Lee Nisley
Newcomer Lee Nisley is a declarant linked to Myriad Genetics INC and Coherus Oncology, Inc., where he is a Director. He has 7 filings in total, and across the 7 recent filings sampled, the reported sell volume is EUR 145328, with a date range from 2021-06-04 to 2026-06-09 and a modal transaction nature of Attribution.
